chemical inhibits protein chemical has protein target as antagonist chemical inhibits in vitro invasion of virus has role has role secondary carboxamide anticoronaviral agent imidazoles pyridines antineoplastic agent tyrosine kinase inhibitor pyrimidines secondary amino compound nilotinib DrugBank:DB04868 nilotinibum 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide nilotinib AMN 107 529.18379 HHZIURLSWUIHRB-UHFFFAOYSA-N 0 chebi_ontology CHEBI:52172 Wikipedia:Nilotinib CAS:641571-10-0 529.51580 PMID: 24841273; PMID: 29557770 https://www.drugbank.ca/drugs/DB04868 LINCS:LSM-1099 Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)cc(c1)C(F)(F)F KEGG:D08953 InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37) C28H22F3N7O nilotinib Drug_Central:1932 AMN107 (trifluoromethyl)benzenes Severe acute respiratory syndrome-related coronavirus tyrosine-protein kinase ABL1 (human) mast/stem cell growth factor receptor Kit (human)